M&A
confidence high
sentiment neutral
materiality 0.50
Boundless Bio amends Serapha merger: RSU conversion, pre-funded warrants, vote standard
Boundless Bio, Inc.
- Amendment No. 1 (8/28/26) to the June 22, 2026 merger agreement among Boundless Bio, Boulder Merger Sub, and Serapha Bio.
- Serapha RSUs (vested or unvested) convert into Assumed RSUs covering Boundless Bio common stock at the Exchange Ratio.
- Pre-funded warrants with $0.00001 exercise price issued as Merger Consideration for holders exceeding Beneficial Ownership Limits (0–19.99%).
- Vote standard for increasing authorized Boundless Bio shares changed to majority of shares properly cast, not majority outstanding.
- Company Pre-Closing Financing definitions clarified; cash proceeds of at least the minimum amount required by 8/28/26 close.